Gene Knockout

Gene Knockout designates targeted disruption or deletion of specific genes eliminating their function, serving as powerful research tool for understanding gene roles in biological processes, disease mechanisms, and validating therapeutic targets. This genetic manipulation approach creates loss-of-function mutations through methods including homologous recombination, CRISPR-Cas9 genome editing, or transient knockdown using RNA interference.

The biopharmaceutical industry extensively employs gene knockout for target validation, disease modelling, and mechanistic research. Target validation through knockout confirms gene involvement in disease processes, with knockout animal models recapitulating human disease features supporting target selection decisions. Functional genomics screens use pooled CRISPR libraries creating knockout cell populations systematically disrupting thousands of genes. Manufacturing cell lines sometimes employ targeted knockouts eliminating proteases degrading products or removing viral susceptibility genes. Conditional knockout systems enable tissue-specific or temporally controlled gene disruption. As genome editing technologies mature and human genetic databases reveal loss-of-function variant effects, gene knockout approaches continue providing essential insights validating therapeutic targets.